Immunization with homologous Pseudomonas aeruginosa pili protects against ocular disease. 1993

X L Rudner, and R S Berk, and L D Hazlett
Department of Anatomy/Cell Biology, Wayne State University, Detroit, MI 48201.

The prophylactic effect of pili in prevention or amelioration of Pseudomonas aeruginosa ocular disease was examined in mice, using both systemic and topical protection approaches. At 30 days postinfection, a significant number of animals actively or passively immunized with pili homologous to pseudomonal strain American Type Culture Collection 19660 were protected from ocular disease when compared with similarly infected phosphate-buffered saline controls. Although exogenously mixing strain 19660 with either homologous or heterologous (PAK/PR1) pili before topical application of the inoculum significantly inhibited bacterial adhesion in vitro, in similarly designed in vivo studies, animals were not protected from corneal disease. Neither was significant ocular protection conferred using pili (PAK/PR1) heterologous to the infecting strain (19660) for active or passive immunization of mice, nor in studies involving exogenous mixing of PAK/PR1 pili or its pili-specific monoclonal antibody with strain 19660 prior to topical application of the latter. These results provide evidence that significant ocular protection is achieved by either active or passive, but not topical, immunization with pili homologous to the infecting bacterial strain and that immunization with pili heterologous to the infecting bacterial strain fails to provide protection against ocular disease, despite the fact that heterologous pili are highly effective at decreasing bacterial binding to cornea in vitro.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010861 Fimbriae, Bacterial Thin, hairlike appendages, 1 to 20 microns in length and often occurring in large numbers, present on the cells of gram-negative bacteria, particularly Enterobacteriaceae and Neisseria. Unlike flagella, they do not possess motility, but being protein (pilin) in nature, they possess antigenic and hemagglutinating properties. They are of medical importance because some fimbriae mediate the attachment of bacteria to cells via adhesins (ADHESINS, BACTERIAL). Bacterial fimbriae refer to common pili, to be distinguished from the preferred use of "pili", which is confined to sex pili (PILI, SEX). Bacterial Fimbriae,Bacterial Pili,Common Fimbriae,Common Pili,Pili, Bacterial,Pili, Common,Bacterial Fimbria,Bacterial Pilus,Common Fimbria,Common Pilus,Fimbria, Bacterial,Pilus, Bacterial,Fimbria, Common,Fimbriae, Common,Pilus, Common
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001422 Bacterial Adhesion Physicochemical property of fimbriated (FIMBRIAE, BACTERIAL) and non-fimbriated bacteria of attaching to cells, tissue, and nonbiological surfaces. It is a factor in bacterial colonization and pathogenicity. Adhesion, Bacterial,Adhesions, Bacterial,Bacterial Adhesions
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

X L Rudner, and R S Berk, and L D Hazlett
June 2006, FEMS immunology and medical microbiology,
X L Rudner, and R S Berk, and L D Hazlett
January 2017, Journal of immunology research,
X L Rudner, and R S Berk, and L D Hazlett
November 2022, NPJ vaccines,
X L Rudner, and R S Berk, and L D Hazlett
March 2007, Proceedings of the National Academy of Sciences of the United States of America,
X L Rudner, and R S Berk, and L D Hazlett
October 1973, Infection and immunity,
X L Rudner, and R S Berk, and L D Hazlett
September 2015, Journal of microbiology and biotechnology,
X L Rudner, and R S Berk, and L D Hazlett
January 1971, Canadian journal of comparative medicine : Revue canadienne de medecine comparee,
X L Rudner, and R S Berk, and L D Hazlett
November 2014, Science translational medicine,
Copied contents to your clipboard!